Ander Estella‐Hermoso de Mendoza

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

Edurne San José‐Eneriz, Xabier Agirre, Obdulia Rabal et al. · Nature Communications · 2017 · 170 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease

Carmen Roncal, E. Martínez-Aguilar, Josune Orbe et al. · Scientific Reports · 2019 · 157 citations · Full text

Medicine, Cardiology, Pharmacology +15

Lipid raft-targeted therapy in multiple myeloma

Faustino Mollinedo, Janis de la Iglesia-Vicente, Consuelo Gajate et al. · Oncogene · 2010 · 123 citations

Medicine, Cancer Biology, Oncology +14

In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma

Ander Estella‐Hermoso de Mendoza, Véronique Préat, Faustino Mollinedo et al. · Journal of Controlled Release · 2011 · 110 citations · Full text

Pharmacy, Oncology, Pharmaceutics +14

GPR55: A therapeutic target for Parkinson's disease?

Marta Celorrio, Estefanía Rojo-Bustamante, Diana Fernández‐Suárez et al. · Neuropharmacology · 2017 · 107 citations

Medicine, Neuroscience, Pharmacology +12